ERIN HARRELL: Open Payments
NPI 1497123343 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 75 payments from 12 companies in 2025. Trend: 2023 $2,024 · 2024 $1,489 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $227 |
| ABBVIE INC. | 18 | $202 |
| Collegium Pharmaceutical, Inc. | 12 | $165 |
| Neurocrine BioSciences, Inc. | 10 | $163 |
| Supernus Pharmaceuticals, Inc. | 9 | $158 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Alkermes, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: CAPLYTA, VRAYLAR, Jornay PM, INGREZZA, Qelbree, Auvelity, ARISTADA, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
